Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: SvájcFázis nélkül

Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)

A legfontosabb adatok

Ki végzi
University Hospital, Basel, Switzerland
Hol
Basel (Svájc)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
705 fő, tervezett
Kezdés
2026. okt. 1.
Várható befejezés
2028. szept.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Single Suture-Based Vascular Closure Device
  • Extravascular Collagen Plug-Based Closure Device
A regiszteradat frissítve
2026. augusztus 4.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a planned TAVI (a heart valve replacement done through a tube) through the main artery in the leg. It compares two ways to close the artery afterwards.

Életkor
18 years or older.
Nem
All sexes can join.
A betegség stádiuma
People with a planned, non-emergency TAVI through the leg artery. The local Heart Team must judge they can have this procedure and the large artery closure.

A részvétel fő kizáró okai

  • TAVI planned through another route than the leg artery, or an emergency TAVI.
  • Leg artery size, calcium build-up or twisting that does not allow the standard closure devices.
  • Active infection at the planned access site, or severe allergy to bovine tissue, collagen or parts of Perclose ProGlide/ProStyle or Angio-Seal.
  • Severe bleeding problems, active major bleeding, or unable to take blood thinners or antiplatelet drugs.
  • Pregnant or breastfeeding, or taking part in another device or drug trial.

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient is at least 18 years of age at the time of screening
  • Patient is scheduled to undergo elective transcatheter aortic valve implantation (TAVI) via transfemoral arterial access
  • Patient is deemed suitable for transfemoral TAVI and large-bore vascular access closure by the local Heart Team
  • Patient (or legally authorized representative) provides written informed consent prior to initiating any study-related procedures
  • Patient is willing and able to comply with all specified study procedures, follow-up visits, and clinical evaluations

Ki nem vehet részt

  • Concurrent participation in another interventional clinical trial investigating cardiovascular devices or drugs that could confound study endpoints
  • Known active, unresolved local or systemic infection at the planned vascular access site
  • Known severe allergy or hypersensitivity to bovine tissue, collagen, or any component of the study closure devices (Perclose ProGlide/ProStyle or Angio-Seal) that cannot be adequately premedicated
  • Severe bleeding diathesis, active major bleeding, or absolute contraindication to standard periprocedural anticoagulation or antiplatelet therapy
  • Planned TAVI procedure via non-femoral arterial access (e.g., transapical, transaortic, subclavian/axillary, or carotid access)
  • Emergency or non-elective TAVI procedure
  • Target main femoral artery vessel diameter, calcification, or tortuosity judged unsuitable for standard percutaneous large-bore vascular closure device deployment
  • Patient is pregnant or breastfeeding
  • Patient belongs to a vulnerable population (e.g., individuals deprived of liberty, under guardianship, or unable to give informed consent)

Helyszínek itt: Svájc

  • University Heart Center Basel, University Hospital BaselBasel, SvájcContact: Max Wagener, MD, MScToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this clinical trial is to compare two strategies for closing the main artery access site in adult patients undergoing transcatheter aortic valve implantation (TAVI) through a blood vessel in the leg (transfemoral access).

A teljes eredeti leírásKevesebb

The main questions it aims to answer are:

Does using a single suture device lower the rate of access-related vascular complications compared to using a hybrid combination of a suture device and a plug-based closure device? How do the two closure strategies compare regarding bleeding complications, procedure time, and time to complete vessel sealing?

Researchers will compare a single-suture closure strategy to a hybrid closure strategy (one suture plus one plug-based device) to see if using a single suture reduces vessel-related complications and improves patient safety after TAVI.

Participants will:

Undergo standard pre-procedure screening and TAVI via the main artery in the leg as part of routine medical care.

Receive an initial single-suture placement before the large TAVI delivery system is inserted.

Be evaluated after sheath removal for initial bleeding control; qualifying participants will then be randomly assigned (1:1) to either receive no additional device (single suture group) or receive a plug-based closure device (hybrid group).

Have their heart and access site monitored during hospitalization, including laboratory checks and imaging prior to discharge.

Complete a 72-hour safety and complication evaluation.

A vizsgálat 2 csoportja

  • Single-Suture StrategyMár használt kezelés, összehasonlításként

    Single suture-based vascular closure device (VCD) pre-placed prior to sheath insertion.

    Kezelés: Single Suture-Based Vascular Closure Device

  • Hybrid Strategy (Suture + Plug)A vizsgált kezelés

    Single suture-based VCD combined with an extravascular plug-based VCD (Angio-Seal®)

    Kezelés: Extravascular Collagen Plug-Based Closure Device

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
SEAL-TAVI - Suture vs combinEd Closure strAtegies in Large-bore Access After TAVI
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. augusztus 4.